Clinical trial No longer in our active list Observational Ages 18 to 100

Observing the positioning of glaucoma microstents after surgery

Official title: Post-operative Anterior Segment OCT Evaluation of Trabecular Microstent Positioning and the Impact on Intraocular Pressure

Run by University of Utah · NCT06666751 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study looks at how well glaucoma microstents are positioned after surgery in adults who also had cataract surgery, to see if their placement affects eye pressure over time.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment116 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Murray, Utah)
Trial IDNCT06666751 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have undergone Hydrus microstent or iStent Inject placement at the Moran Eye Center.

Probably not a fit

Patients who have had their stent removed or have a history of anterior segment trauma or anatomical alterations will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the long-term outcomes of glaucoma microstent surgery in adults who have also undergone cataract surgery within the last two years. Participants will undergo a one-time eye exam and Optical Coherence Tomography (OCT) to assess the positioning of microstents and the dilation of Schlemm's canal. Researchers will analyze medical records to gather data on surgeon experience and the effectiveness of the surgery based on changes in intraocular pressure. The study seeks to determine the frequency of microstent mispositioning and its impact on intraocular pressure post-surgery.

Why it matters

Potential benefit: If successful, this study could improve the understanding of microstent positioning and its effects on intraocular pressure, leading to better surgical outcomes for glaucoma patients.

How similar studies have gone: While this study focuses on specific outcomes related to microstent positioning, similar observational studies have shown promise in understanding surgical outcomes in glaucoma treatment.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any adult glaucoma patient (age 18+) who underwent Hydrus microstent or iStent Inject placement at the Moran Eye Center.

Exclusion Criteria:

* Any patient who subsequently had to have their stent removed for any reason, any patient with a history of trauma to the anterior segment or reconstruction altering typical anatomy.

Where it's running

  • Moran Eye Center
    Murray, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.